Cycloleucine

Cycloleucine

SCHEMBL8495

NC1(C(=O)O)CCCC1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cycloleucine SCHEMBL21462057 1.00 NSD2 (0.50) —
Cycloleucine SCHEMBL1711763 0.97 NSD2 (0.48) —
SCHEMBL744894 0.97 NSD2 (0.48) —
SCHEMBL59793 0.97 NSD2 (0.48) —
SCHEMBL62221 0.97 NSD2 (0.48) —
SCHEMBL15095885 0.97 NSD2 (0.48) —
Cycloleucine SCHEMBL3164459 0.97 NSD2 (0.48) —
SCHEMBL21423145 0.97 NSD2 (0.48) —
Cycloleucine SCHEMBL3674853 0.97 NSD2 (0.48) —
Cycloleucine SCHEMBL1704308 0.97 NSD2 (0.48) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 9233 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122084906-A Plasma metabolism marker for early diagnosis or prediction of gestational diabetes mellitus and application thereof — 2026-05-26 — — CN claimed
US-12630588-B2 Bicyclic peptide ligands specific for CD137 BICYCLETX LIMITED (GB) 2026-05-19 — — US claimed
WO-2026099897-A1 NOVEL LINKERS AND ITS PREPARATION METHODS THEREOF ZYDUS LIFESCIENCES LIMITED (IN) 2026-05-15 — — WO claimed
US-20260124313-A1 SITE-SPECIFIC COVALENT LIGATION OF HUMAN SERUM ALBUMIN UNIV CALIFORNIA (US) 2026-05-07 — — US claimed
US-12600699-B2 Thiosemicarbazates and uses thereof THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) 2026-04-14 — — US claimed
US-20260098072-A1 METHODS OF STIMULATING APPETITE AND/OR INCREASING BODY WEIGHT USING NON-NATURALLY OCCURRING MELANOCORTIN RECEPTOR ANTAGONIST ANALOGS ENDEVICA BIO INC (US) 2026-04-09 — — US claimed
US-20260060962-A1 METHODS AND AGENTS THAT STIMULATE MITOCHONDRIAL TURNOVER FOR TREATING DISEASE CAPACITY BIO INC (US) 2026-03-05 — — US claimed
US-12551535-B2 Peptide pharmaceuticals for insulin resistance MEDERIS DIABETES, LLC (US) 2026-02-17 — — US claimed
EP-4127157-B1 MODIFIED DIPEPTIDE CLEAVASES, USES THEREOF AND RELATED KITS ENCODIA INC (US) 2026-02-11 — — EP claimed
EP-3967714-B1 VINYL ALCOHOL-AMINO ACID ESTER COPOLYMER, THEIR PREPARATION AND USES SEKISUI CHEMICAL CO LTD (JP) 2026-01-07 — — EP claimed
US-4759866-A Mixture of alkali metal salts and 1-amino-cyclopentane-carboxylic acid and derivatives or its precursor as gas scrubber EXXON RESEARCH AND ENGINEERING COMPANY (US) 1988-07-26 — — US claimed
EP-0245961-A1 Acid gas scrubbing composition and process EXXON RESEARCH AND ENGINEERING COMPANY (US) 1987-11-19 — — EP claimed
US-4436910-A SAPONIFICATION DEGUSSA AKTIENGESELLSCHAFT (DE) 1984-03-13 — — US claimed
US-4427762-A DEVELOPMENT WITH ALKALINE DEVELOPER MIXTURE KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) 1984-01-24 — — US claimed
EP-0036713-B1 ANGIOTENSIN CONVERTING ENZYME INHIBITORS UNIVERSITY OF MIAMI (US) 1984-01-18 — — EP claimed
EP-0082015-A1 Method of forming an image with a photographic cuprous halide material KONICA CORPORATION (JP) 1983-06-22 — — EP claimed
EP-0024172-B1 ANTITUMOR AND IMMUNOSUPPRESSIVE 4-CARBAMOYLIMIDAZOLIUM-5-OLATE DERIVATIVES, PHARMACEUTICAL COMPOSITION AND PRODUCTION THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1983-05-11 — — EP claimed
EP-0036713-A2 Angiotensin converting enzyme inhibitors UNIVERSITY OF MIAMI (US) 1981-09-30 — — EP claimed
US-3981915-A Amides of 1-aminocyclopentane carboxylic acid AMERICAN HOME PRODUCTS CORPORATION (US) 1976-09-21 — — US claimed
US-3976692-A ANALGESIC AMERICAN HOME PRODUCTS CORPORATION (US) 1976-08-24 — — US claimed
Send feedback